Amneal Pharmaceuticals, Inc. AMRX Other — Net revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s other — net revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s other — net revenue?
- Amneal Pharmaceuticals, Inc. (AMRX) reported other — net revenue of $7.1M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s other — net revenue changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s other — net revenue increased by 11.4% year-over-year, from $6.37M to $7.1M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s other — net revenue?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s other — net revenue has grown at a 25.2% compound annual growth rate (CAGR), from $12.54M to $30.79M.
- What does other — net revenue mean?
- This metric represents the total revenue generated from business activities, products, or services that do not fall under the company's primary reportable segments. It captures income from ancillary operations or non-core business lines that contribute to the overall top-line performance. Monitoring this figure helps investors understand the scale and growth trajectory of secondary revenue streams outside of the company's main strategic focus areas.